Abstract

Simultaneous RP-HPLC estimation of cilnidipine and telmisartan in combined tablet dosage form

This paper describes a simple, accurate, and validated reverse-phase high-performance liquid chromatographic method for the simultaneous quantification of Telmisartan and Cilnidipine as the bulk drug and in tablet dosage forms. Separation was carried out on Jasco HPLC system equipped with HiQ sil C18 HS column (250 × 4.6 mm i.d.) and PDA detector using Methanol: 40 mM Potassium dihydrogen ortho phosphate buffer (pH 3) (90:10, v/v)) as the mobile phase, and detection was carried out at 245 nm. Results were linear in the range of 1-10 μg mL-1 for Cilnidipine and 5-30 μg mL-1 for Telmisartan. The method was successfully applied for the analysis of drugs in pharmaceutical formulation. Results of the analysis were validated statistically and by recovery studies


Author(s): Prajakta Pawar, Santosh V. Gandhi, Padmanabh B. Deshpande, Suvarna Vanjari and Swapnil U. Shelar

Abstract | PDF

Share This Article
Awards Nomination 17+ Million Readerbase
Google Scholar citation report
Citations : 5682

Der Chemica Sinica received 5682 citations as per Google Scholar report

Der Chemica Sinica peer review process verified at publons
Abstracted/Indexed in
  • Google Scholar
  • Open J Gate
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • Directory of Research Journal Indexing (DRJI)
  • Publons
  • MIAR
  • International Committee of Medical Journal Editors (ICMJE)
  • Serials Union Catalogue (SUNCAT)
  • Geneva Foundation for Medical Education and Research
  • Secret Search Engine Labs
  • Euro Pub
  • CAS (Chemical Abstracting Services)
  • University of Barcelona

View More »

Flyer image
T�rkiye'nin Yeni Nesil Bahis Adresi Matadorbet giris Adresi G�ncellenmistir!